Elizabeth Pradel

2.3k total citations · 1 hit paper
37 papers, 1.8k citations indexed

About

Elizabeth Pradel is a scholar working on Genetics, Molecular Biology and Molecular Medicine. According to data from OpenAlex, Elizabeth Pradel has authored 37 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Genetics, 19 papers in Molecular Biology and 13 papers in Molecular Medicine. Recurrent topics in Elizabeth Pradel's work include Bacterial Genetics and Biotechnology (17 papers), Antibiotic Resistance in Bacteria (13 papers) and Yersinia bacterium, plague, ectoparasites research (9 papers). Elizabeth Pradel is often cited by papers focused on Bacterial Genetics and Biotechnology (17 papers), Antibiotic Resistance in Bacteria (13 papers) and Yersinia bacterium, plague, ectoparasites research (9 papers). Elizabeth Pradel collaborates with scholars based in France, United States and United Kingdom. Elizabeth Pradel's co-authors include Jonathan J. Ewbank, Carl A. Schnaitman, Jean‐Marie Pagès, P Boquet, Yun Zhang, Nathalie Pujol, Cornelia I. Bargmann, Tohey Matsuyama, Craig T. Parker and Camille Locht and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Elizabeth Pradel

36 papers receiving 1.8k citations

Hit Papers

A Model of Bacterial Intestinal Infections in Drosophila ... 2007 2026 2013 2019 2007 50 100 150 200 250

Peers

Elizabeth Pradel
Sachiko Miyata United States
Min Cao China
Man-Wah Tan United States
Creg Darby United States
Sachiko Miyata United States
Elizabeth Pradel
Citations per year, relative to Elizabeth Pradel Elizabeth Pradel (= 1×) peers Sachiko Miyata

Countries citing papers authored by Elizabeth Pradel

Since Specialization
Citations

This map shows the geographic impact of Elizabeth Pradel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Pradel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Pradel more than expected).

Fields of papers citing papers by Elizabeth Pradel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Pradel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Pradel. The network helps show where Elizabeth Pradel may publish in the future.

Co-authorship network of co-authors of Elizabeth Pradel

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Pradel. A scholar is included among the top collaborators of Elizabeth Pradel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Pradel. Elizabeth Pradel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Plé, Coline, Giuseppe Sicoli, Ravil R. Petrov, et al.. (2024). Small molecule MarR modulators potentiate metronidazole antibiotic activity in aerobic E. coli by inducing activation by the nitroreductase NfsA. Journal of Biological Chemistry. 300(7). 107431–107431.
2.
Jiménez-Castellanos, Juan-Carlos, Elizabeth Pradel, Catherine Piveteau, et al.. (2023). Optimization of pyridylpiperazine-based inhibitors of the Escherichia coli AcrAB-TolC efflux pump. European Journal of Medicinal Chemistry. 259. 115630–115630. 6 indexed citations
3.
Jiménez-Castellanos, Juan-Carlos, et al.. (2023). Characterization of pyridylpiperazine-based efflux pump inhibitors for Acinetobacter baumannii. JAC-Antimicrobial Resistance. 5(5). dlad112–dlad112. 5 indexed citations
4.
Jiménez-Castellanos, Juan-Carlos, Laurye Van Maele, Elizabeth Pradel, et al.. (2023). Pyridylpiperazine efflux pump inhibitor boosts in vivo antibiotic efficacy against K. pneumoniae. EMBO Molecular Medicine. 16(1). 93–111. 12 indexed citations
5.
Plé, Coline, Heng-Keat Tam, Juan-Carlos Jiménez-Castellanos, et al.. (2022). Pyridylpiperazine-based allosteric inhibitors of RND-type multidrug efflux pumps. Nature Communications. 13(1). 115–115. 46 indexed citations
6.
Ricard, Isabelle, et al.. (2020). A refined model of how Yersinia pestis produces a transmissible infection in its flea vector. PLoS Pathogens. 16(4). e1008440–e1008440. 21 indexed citations
7.
Reboul, A., Nadine Lemaître, Marie Titécat, et al.. (2014). Yersinia pestis Requires the 2-Component Regulatory System OmpR-EnvZ to Resist Innate Immunity During the Early and Late Stages of Plague. The Journal of Infectious Diseases. 210(9). 1367–1375. 29 indexed citations
8.
Sierra-Gallay, I. Li de la, Noureddine Lazar, Arnaud Leroy, et al.. (2014). Functional and Structural Analysis of HicA3-HicB3, a Novel Toxin-Antitoxin System of Yersinia pestis. Journal of Bacteriology. 196(21). 3712–3723. 28 indexed citations
9.
Iguchi, Atsushi, Yutaka Nagaya, Elizabeth Pradel, et al.. (2014). Genome Evolution and Plasticity of Serratia marcescens, an Important Multidrug-Resistant Nosocomial Pathogen. Genome Biology and Evolution. 6(8). 2096–2110. 150 indexed citations
10.
Pradel, Elizabeth, et al.. (2014). New Insights into How Yersinia pestis Adapts to Its Mammalian Host during Bubonic Plague. PLoS Pathogens. 10(3). e1004029–e1004029. 41 indexed citations
11.
Derbise, Anne, Elizabeth Pradel, Isabelle Ricard, et al.. (2013). Inheritance of the Lysozyme Inhibitor Ivy Was an Important Evolutionary Step by Yersinia pestis to Avoid the Host Innate Immune Response. The Journal of Infectious Diseases. 207(10). 1535–1543. 20 indexed citations
12.
Lemaître, Nadine, Isabelle Ricard, Elizabeth Pradel, et al.. (2012). Efficacy of Ciprofloxacin-Gentamicin Combination Therapy in Murine Bubonic Plague. PLoS ONE. 7(12). e52503–e52503. 11 indexed citations
13.
Nehme, Nadine T., Samuel Liégeois, Beatrix Kele, et al.. (2007). A Model of Bacterial Intestinal Infections in Drosophila melanogaster. PLoS Pathogens. 3(11). e173–e173. 281 indexed citations breakdown →
14.
Masi, Muriel, Jean‐Marie Pagès, & Elizabeth Pradel. (2003). Overexpression and purification of the three components of the Enterobacter aerogenes AcrA–AcrB–TolC multidrug efflux pump. Journal of Chromatography B. 786(1-2). 197–205. 12 indexed citations
15.
Pradel, Elizabeth, Nicole Guiso, Franco D. Menozzi, & Camille Locht. (2000). Bordetella pertussisTonB, a Bvg-Independent Virulence Determinant. Infection and Immunity. 68(4). 1919–1927. 41 indexed citations
16.
Gillet, Daniel, et al.. (1992). Insertion of a disulfide-containing neurotoxin into E.coil alkaline phosphatase: the hybrid retains both biological activities. Protein Engineering Design and Selection. 5(3). 273–278. 31 indexed citations
17.
Klena, John D., Elizabeth Pradel, & Carl A. Schnaitman. (1992). Comparison of lipopolysaccharide biosynthesis genes rfaK, rfaL, rfaY, and rfaZ of Escherichia coli K-12 and Salmonella typhimurium. Journal of Bacteriology. 174(14). 4746–4752. 49 indexed citations
19.
Pradel, Elizabeth, Christian Marck, & P Boquet. (1990). Nucleotide sequence and transcriptional analysis of the Escherichia coli agp gene encoding periplasmic acid glucose-1-phosphatase. Journal of Bacteriology. 172(2). 802–807. 19 indexed citations
20.
Pradel, Elizabeth & P Boquet. (1989). Mapping of the Escherichia coli acid glucose-1-phosphatase gene agp and analysis of its expression in vivo by use of an agp-phoA protein fusion. Journal of Bacteriology. 171(6). 3511–3517. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026